Member Info for Pingu777

Haha ok.

Stu, like you have you have your movements set by an atomic clock, when the SP goes up, you disappear.

Its as if you buy and keep quiet as it rises. Bonkers theory I know.

I suspect we wont hear much from you as the SP keeps on rising - for this non-extraordinary CAR T treatment you still quite clearly don't understand.

You keep me going Stu, I feed off your energy. Plz give us an update soon. I'm still waiting for your exposé of HG CT 1 and Haywain with your evidence of treatment that is currently better than HEMO CAR T. It must be good with this build up. I've got tired of doing a fingertip drumroll already.

Pumpky, just think how many shares you could have had if you didnt lose so much cash trying to trade when you dont know what you're doing.

Also, you could have shares with warrants if you were not such a dislikeable chap. Laughy face.

Please sell up soon. Good man.

It's time we re-rated to a more realistic market cap for where the company is at in terms of its overall assets and HG CT 1 in particular at this moment.

No news required tomorrow. The right people are getting to know about HEMO.

Youre thick Pumpky.

The warrant holders are here for the big money. Squeeze that into your tiny mind.

Thanks Stu. I feel much safer under your stewardship.

You’ve shown a clear expert understanding of HEMO. Incomparable deep dive facts, views and opinions on the potential success of HEMO. Incomparable knowledge. An understanding the likes of no reader has ever seen before on LSE.

I spoke to someone earlier who wanted to know what big or medium pharma might be waiting to see? What milestones might be a trigger to get involved?

I said maybe the completion of the first cohort safety profiling ending day 28 on p3. Maybe Six month efficacy info on p1 as well. Also that the paediatric trial gets the nod from IRB. All big milestones.

But he said no. None of this counts Pingu. We all know Big Pharma is waiting for Stu to give it the green light on LSE when he’s happy.

I said I know he’s a big hitter but I don’t think he knows anything about HG CT 1. Like nothing. So not sure how he might manage this?

Exciting times.

Here it comes, the big reveal.

Dazzle us Stu. Go.

How many warrants did you get Pumpky?

“Something is happening…”

I’m going to go with:-

-it’s safe

-it works

-market cap under £10m and worth 50x more. (Even this early).

Stu talking BS again?

Shocked…. NOT.

What was the safety profile in the trial you reference Stu?

I don’t think it will take a couple of years before Hemo does a deal — the window is much shorter. Proof-of-concept has already been established with clear evidence of safety and early signals of efficacy in one of the hardest indications. The FDA’s decision to greenlight paediatrics isn’t just about safety either — regulators only move children forward when they believe there is meaningful benefit, which is a huge external validation. Medium sized Pharma won’t wait around for years because by then the majors will be circling and the price will be on a completely different level. At today’s market cap Hemogenyx is absurdly undervalued, and with further data and the paediatric arm starting up that gap will close very quickly. Yes, Vlad may do another raise, but that’s just a bridge. The real story is that strategic discussions will happen on 2025 data, not years down the line.

We know you're desperate to drum up a bit of support for Avacta - but with all due respect, Hemo is nothing like Avacta. Avacta uses existing ageing chemo treatments that make it necessary for them to extensively prove that its superiority to existing treatments and long trials are needed to provide such data. For HEMO, thats simply not the case. In fact, one could say Hemo have already proved the clearsuperiority of HG CT 1 above anything ever designed before!

I'm very much looking forward to the next few months.

Very happy with the growing positive sentiment swing here. Hopefully the share price continues to grow as the trial progresses.

I've everything crossed we can land a 100% clean safety profile on cohort one, patients 1-3. Get Vladik into a material position of power for his ongoing discussions with the big boys.

Alder is a live case study of Dunning Kruger.

The Arts knew this. Its why he's here!

What do you like about HEMO?

Im pretty certain you know nothing about development funding in pharma.

But nice play. Why do you like HEMO please?

But you open with your shares are worth a can off coke?

Consistency is important.

More about timing. Why now?

You didnt mention investing in HEMO. But you mocked it. by being here and saying your 6 shares are worth nothing pennies.

I'd like more information than how you're a show funder/creator. Pretty much irrelevant here.

What do you like about HEMO that made you invest?

Why u here then?